Recent Updates
Recently added Catalysts
ZLAB

Zai Lab Statement on Executive Management Team’s Agreement on Share Activities – Zai Lab Limited

Key Takeaway: Zai Lab Statement on Executive Management Team’s Agreement on Share Activities – Zai Lab Limited
Price reaction · baseline $15.4 (2024-04-10 close) · hit after-hours · 1 other ZLAB headline(s) in the window, move may be shared
day 0 close · peak
-2.5%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer

Full Press Release Details

Zai Lab Statement on Executive Management Team’s Agreement on Share Activities – Zai Lab Limited.
Last updated: Apr 11, 2024